RentSafe is a tech start-up started in 2016 and has launched a new and much more intelligent property platform in February 2018. RentSafe will disrupt an industry with outdated principles and processes and make it easier for you to find and rent a property.We uses verified data to protect and match tenants with landlords and places faster, easier and smarter. We protect your privacy, security and money, and inform you throughout the whole process. Trust and transparency are the key words!

At Famly, we are on a mission to make everyday life easier for parents, children and teachers around the world. Founded in 2013, Famly is now used by thousands of parents every day in Denmark, Germany, US and UK.  It’s no small task, and that’s why we’re always on the lookout for more talented people to help us do what we do even better. Over the years, our team has grown with the development and expansion of our platform.  You can learn more about us here: https://famly.co/about/

no-more is a highly ambitious startup founded in mid-2016 by Anders Thomsen.It is a Danish B2B service company specialized in ad hoc outsourcing. Services include tailor-made PowerPoint presentations from clients' handwritten notes, brush up presentation drafts, improve consistency and provide powerful visual enhancements, so that business professionals save much needed spare time and thereby enhance productivity. For more information: www.nomorehours.com

Rodinia Generation was created, with one goal in mind: Changing the fashion industry for the better. With a strong ambition to drive forward the transformation, from being one of the world’s most polluting industries to becoming a digital and sustainable one, The Green Fashion Factory was setup in Copenhagen in 2020, where we produce clothes sustainably and ultra-fast. Rodinia has been recognized by fashion companies, investors and public funding bodies (i.e. Innovation Fund Denmark) incl. the European Patent-office and has secured €2M from investors and grants.

Xilium is a software and consultancy company that has specialized in providing clinical decision support and regulatory compliant software to handle healthcare communication between medical professionals and patients. To be a bit more specific, we develop and market the product, DizzyGuide. In basic terms, DizzyGuide is a patient questionnaire (for patients with dizziness symptoms) that, once answers have been processed by the algorithm, will provide healthcare professionals with guidance to ensure the shortest and best patient journey through the healthcare system. The questionnaire and algorithm which our software is based on were initially developed by experts at Mayo Clinic, The number 1 hospital in the World. Today, the development of the questionnaire and algorithm is continued in collaboration between members of our advisory board: Xilium, Mayo Clinic, Michigan Medicine, and the University of Lund, in Sweden. NOTE. we are in the process of changing our name. Therefore the link to our old website.

At reVIRTUE, we truly believe in decentralized ways of reimagining the future. We are a young startup convinced that there is an urgent need for better infrastructures that determine our everyday lives. The status quo is simply not good enough. The COVID-19 pandemic has been a stark wake up call, it has revealed the faults in the systems that makeup our modern lives. With the creative industry being one of the hardest hit, creativity has been dampened with the stress of the moment, but now, more than ever, we need creativity to flourish in order to usher in the brighter futures we KNOW are possible. reVIRTUE is a decentralized platform that will link creators to demanders through cognitive automation. The aim is to defy the current top-down creative industry with economic infrastructures that are resilient by design and distributive by default. It will introduce a self-sustaining ecosystem where creators can own their prospects with dignity and can focus on actually making transformative work. A new status quo is waiting to be born.

Mendonca Biomed is an early stage life science startup with the aim to develop and validate novel biomarker for the early detection of viral infections in blood with an affordable yet simple detection method that can be universally applied. The company was originally founded by myself Kevin Mendonca in India based on his 15 years of accumulative research knowledge. Preliminary data on the utility of viral miRNA biomarkers for the screening of blood for transfusion transmitted viral infections, which are potentially superior to the currently available markers, and a simplified assay that is cost effective and can be universally adapted, were developed in India. However, due to an innate lack of infrastructure and funding opportunities in India, I applied for the startup Denmark program to move the company to the medicon valley. I recently moved to Demark, registered a privately owned company and currently in pursue of funding to validate the viral miRNA biomarkers for the early detection of HIV, HBV and HCV in donated blood. Around the world, more than 92 million blood donations are collected every year. Screening of donated blood and derived products, for HIV, HBV and HCV is mandatory worldwide. Screening is a key safety measure in protecting recipients from transfusion transmitted infections, especially in developing nations in Africa and Asia, where the donated blood is not processed because of high costs and lack of infrastructure. Moreover, in emergency situation like natural calamities, disasters and sudden outbreaks, the currently available methods are inadequate for on-site screening. Serological testing (antigen and antibody detection assays) have historically been the foundation of blood screening but with huge drawbacks of long window periods. Newer strategies like the PCR based amplification viral genomic DNA/RNA in blood have helped shorten the window period but have not eliminated it. PCR assays have also been known to fail in low viremia and/or suboptimal amplification efficiency. They are far more expensive than the serological assay, requires expertise, specialized equipment and a molecular biology setup, which is not available in the resource poor settings of the developing countries. Our solution is to develop and validate novel viral miRNA biomarkers that have the potential to further reduce the window period and use the unique characteristics of these biomarkers to develop a simple, multiplex (3 in 1), inexpensive probe hybridization assay that can be universally utilized in all settings and conditions. Viral miRNA molecules are easy to validate as biomarkers since the presence of vmiRNA’s is a definite indicator of infected cells. Benefit: Multiplex 3 in 1 test. Method as simple to perform as the serological assay with the benefits of a molecular assay. Can be adapted in any setting, even in the field and low resource conditions in developing nations. Potentially, lower window period of detection compared to any biomarkers that are available in the market currently. Value: High throughput, lower turnover time with lower chances of human error. Advantages of a molecular assay with the simplicity and affordability of a serological assay. Does not require specialized setup, infrastructure and highly trained technicians. Potentially, could detect the infections faster than any other tests in the market, lowering the risk of transfusion transmission. Once this platform has been validated, the product line can be expanded to cover all commercially viable viral infections. A HPV assay based on this platform, for example, could be a potential replacement for the invasive PAP test, and can be performed during a routine blood test. The platform can be further adapted to screen for novel viral infections like SARS, MERS, ZIKA etc. It can be also be developed to screen and control other sporadic outbreaks the like Dengue, Chikungunya etc.

For a quick intro pls see: https://drive.google.com/file/d/168TTZsNef43Awmxz3iALMhx2saVk5ihe/view?usp=sharing The problem & the idea Data may be the driver for change, improvement and understanding, in many sectors, amongst these also healthcare. Patient data is an important creator of knowledge both on an individual level but also on a group, regional or country level. On an individual level, patient data may support and build the clinical decisions, it may provide more efficient treatment, both in regard to time and economy and secure that knowledge about the individual is transferred fast and unbiased to the healthcare staff. For the patient, sharing of his/her data will secure a better understanding of the needs and support better diagnosis and treatment. Patient data are collected and noticed in some form in most countries, either on paper or electronically. Many countries have some sort of an electronic patient journal, either on a country level, regionally or locally. However, many countries also still use pen & paper. This challenges the storage and continuity of data collection and transfer. Patient data records in electronic form reduces the risk of losing valuable data but also allows the data to be shared if needed. The acknowledgement of the importance on several levels of having patient data and the absence of a central, regional or local electronic patient data recording system in Sub-saharan African countries (the target region) initiated the idea of looking at how it would be possible to collect and make patient data readily available for treatment, benefitting both patient and caregiver, and in a bigger perspective, for research and strategic healthcare initiative planning. During small initial market and possibility investigations the idea of creating a patient owned electronic healthdata journal app arose. Mobiletechnology is both greatly advantaged and outspread in the target region and the number of mobile consumers are increasing every year. It was and is anticipated, that the possibility of having a central system is, due to structural and financial reasons, not a possibility but to empower the patient with the ownership of own data through an app seemed a possibility. It is important to underline that data must be generated from the healthcare provider and then fed into the patientjournal at the site of the consultation. The idea is to have the most relevant data collected and stored in the app, ie. medication, allergies, blood type, diagnosis and immunizations. The data that will go into the app is transferred from a healthcare provider at the site of the healthcare visit, eg a clinique, hospital, other. That means that the healthcare provider must have access to a tablet or smartphone containing the healthcare provider app which connects to the patients healthcare data app at the visit. Also any healthcare provider with the app will followingly get access to the data from the patient by connecting (and by being given access by the patient) to get patients healthdata app. So, in summary the basic idea is to provide all citizens with a tool that will help them keep track of their most important healthcare related data including completed and planned treatments, diagnosis, tests, allergies etc. The idea is further that the data is owned by the citizens/patients, and not by the non-existing national or any hospital specific system. Upon each contact with the healthcare personnel the patient's information is updated by the healthcare personnel (e.g. symptoms, diagnosis, tests, treatment, next visit etc.) The basic idea/assumption is that no national healthcare system will be developed in near or short-term future, and that a personally owned "electronic patient journal" can have a significant positive impact on the quality of treatments because of a more complete picture of the patient is available at the time, when a diagnosis and treatment is to be decided.

Mads Olesen Holdings is owned by entrepreneur Mads Andreas Olesen. After selling his first companies for more than 100 mio. kroner, he now invests in startups, real estate and more through Mads Olesen Holdings (CVR: 36917997) and subsidiaries. In 2020, Mads Olesen Holdings invested in more than 50 ecommerce businesses through its investment in MXNEY.io, that specializes in alternative ecommerce funding. In 2021, the holding company is looking to add 10 properties to its current portfolio of 19 rental properties.

Vitaro driver en række webportaler med fokus på sundhed, træning, kost, motion og livsstil. Vi søger dig, der er passioneret omkring kost og træning og som kan bidrage med en god energi og et højt humør på vores team. Vi holder til på Frederiksberg i nye og moderne lokaler. Du er altid velkommen til at skrive til hej@vitaro.dk. Vi glæder os til at høre fra dig og ser frem til et fedt samarbejde.

We are a think-tank based out of Copenhagen. We work with global innovators, governments and international organisations to accelerate the global transition towards a circular economy. Innovation is the key to moving away from our current linear to a circular economic model of growth. Hence, we are on a mission to foster circular economy innovations. As part of this mission, we are launching a new initiative called ShopC- the world’s first digital marketplace to buy and sell circular products.

Welcome to Ezensual. Being in touch with your "sensual self" is a key factor for any individual’s happiness. It is a much undervalued state-of-mind and state-of-sense. And we are looking for your help to build a leader in the sensual consumer sector globally! Ezensual will bring together an ideal offer for what the world needs now, in one of the fastest emerging industries in the world, providing above and beyond offers, education and customer service. EZENSUAL will cater to users globally and is commandeered by an international and passionate team with +15 years of market experience. We know our way around the global industry value chain, from manufacturing, distribution and retailing, to marketing, sales, supply and support! The global market for sensuality and sexuality in many ways do not cater to 21st century consumer needs! The "offer" is mostly unfiltered and un-related to the individuals needs and wants. It´s product-pitch based, focusing on sales rather than customer interaction and satisfaction. Ezensual will help you to achieve greater well-being, better sensual experience of life and a stronger more satisfying personal sexuality. We uphold our ultimate superior standards by supplying selectively the world’s leading sensual options and brands to provide fun, innovative, functional, safe, and sensual experiences - and products ... the only toys you will ever need. Ezensual delivers the "EzensualYou".

Fysiofresh hjælper personer med nedsat fysisk funktionsevne til en mere selvstændig og meningsfuld hverdag. Dette gør vi ved at tilbyde fysioterapi af høj kvalitet hjemme hos vores klienter. Fordelene ved hjemmebehandling er, at træningen bliver så relevant og optimal som muligt for klienten og dennes hverdag. Derudover sparer klienten tid og besvær med at arrangere transport og møde op på en bestemt lokation. Vi er autoriseret som privat udekørende fysioterapiklinik hos Styrelsen for Patientsikkerhed

Inspired by art, and more specifically improvised comedy theatre training and techniques, we aim to motivate and stimulate the often suppressed natural skillsets with which human beings are born with: - Creativity and curiosity - Support and respect for oneself and others - Awareness, perception, and focus - Courage and confidence - Trust and openness - Critical thinking and collaboration & Emotional and clear expression. We want to inspire people to develop, and help people reconnect with themselves and others through a fun, open and motivating atmosphere in classes. We foster an environment in which people at any level can move and evolve, both physically and emotionally.

We want to build the leading and most advanced sports betting exchange for trading Football players in Denmark. This will be a new concept on the Danish market introducing a new way for football fans to bet on the sport they love - to increase the excitement around the games and transfers - and earn money on their passion.